LIXT
Lixte Biotechnology Holdings Inc
3.70$
-1.3%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.7% | -16.7% | -25.7% | -36.4% | -32.5% | +32.2% | -21.5% | +357.2% | +134.3% | -14.7% | +145.3% | |
| – | -19.2% | -17.0% | -24.0% | -36.7% | -32.2% | +32.2% | -34.6% | +449.0% | -4.7% | -34.2% | +466.3% | |
| – | -17.7% | -18.8% | -24.0% | -36.9% | -36.6% | +33.3% | -35.9% | +225.5% | +76.8% | -36.3% | +289.8% | |
| – | -17.7% | -18.8% | -24.0% | -36.9% | -36.6% | +33.3% | -35.9% | +502.1% | -4.4% | -36.3% | +289.8% | |
| – | +0.7% | +47.5% | -8.9% | -21.9% | -3.2% | +11.6% | +51.3% | -2.9% | +239.9% | -4.8% | -1.5% | |
| – | +0.7% | +47.5% | -8.9% | -21.9% | -3.2% | +11.6% | +51.3% | -2.9% | +155.7% | -8.1% | +22.5% | |
| – | -99.9% | +239,277.3% | -191.1% | – | – | – | – | – | – | -10.4% | +58.0% | |
| – | -29.1% | +57.4% | -46.7% | -44.6% | +14.2% | +35.2% | -18.1% | +156.0% | +184,928.4% | -99.9% | – | |
| – | -18.9% | -21.7% | -28.2% | -39.1% | -39.5% | +40.1% | -43.8% | +654.0% | +96.7% | -17.8% | +201.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.4% | +0.0% | 0.0% | +0.0% | 0.0% | +9.9% | +10.1% | +126.8% | +684.4% | -77.5% | +23.8% |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.